Tristan Rousselle

Tristan is responsible for the overall strategic direction and investor relations for Aryballe to execute our term vision for the potential of digital olfaction. Prior to founding Aryballe, Tristan was the founder and CEO of PX’Therapeutics which specializes in the development of therapeutic proteins.